Zolmitriptan is a selective serotonin receptor agonist used primarily for the acute treatment of migraine attacks. It belongs to the class of triptamines and works by targeting vascular and neuronal pathways involved in migraine pathophysiology. The drug binds to 5-ht1b and 5-ht1d receptors on cerebral blood vessels and trigeminal nerve endings, leading to vasoconstriction and inhibition of pain signaling. This receptor activation reduces the release of pro-inflammatory neuropeptides such as calcitonin gene-related peptide from peripheral trigeminal neurons. By decreasing the amplitude of cortical spreading depression, Zolmitriptan helps to restore normal electrical activity in the brain during a migraine episode. The vasoconstrictive effect on intracranial arteries contributes to the relief of headache through normalization of dilated blood vessels. Pharmacodynamically, the medication's efficacy is linked to its high affinity for both central and peripheral serotonin receptors, which modulates pain perception and vascular tone. Overall, Zolmitriptan provides symptomatic control of migraine attacks by interrupting the cascade of events that generate acute headache and associated neurological disturbances.

Zolmitriptan is a synthetic serotonin receptor agonist used primarily for the acute treatment of migraine attacks. It selectively binds to 5-ht1b and 5-ht1d receptors in the brain leading to vasoconstriction of peripheral cranial arteries. This constriction reduces pain signals associated with migraine-related vascular dilation. By modulating trigeminal nerve pathways the drug interrupts the cascade of symptom development. Its pharmacological profile also includes partial agonism at 5-ht1b receptors which contributes to its anti-migraine efficacy. Overall the medication provides targeted relief by reversing the neurovascular changes characteristic of migraine.

The most common side effects often include fatigue or a general sense of low energy. Headaches are frequently reported among individuals experiencing this condition. Muscle aches and joint discomfort are also commonly observed. Mild gastrointestinal symptoms such as nausea or stomach upset may appear. Changes in appetite can occur without being severe or persistent. Some people notice temporary skin reactions like slight redness or itching. These effects are usually mild and tend to diminish with continued exposure.

Common side effects of many medications include headache nausea and dizziness. Fatigue is frequently reported among users of various treatments. Some individuals experience mild stomach discomfort after taking certain drugs. Changes in taste or appetite can also occur as a normal response. Mild skin irritation may appear with topical applications. Occasional mild fever has been noted in clinical observations. These effects are generally short lived and resolve without intervention.